All Posts By

Smartkarma Daily Briefs

Daily Brief Utilities: Brookfield Renewable Partners and more

By | Daily Briefs, Utilities Sector

In today’s briefing:

  • Primer: Brookfield Renewable Partners (BEP US) – Oct 2025


Primer: Brookfield Renewable Partners (BEP US) – Oct 2025

By αSK

  • Leading Pure-Play Renewable Power Platform: Brookfield Renewable Partners (BEP) is one of the world’s largest publicly traded, pure-play renewable power platforms, with a diversified portfolio across hydro, wind, solar, and energy transition assets. Its global scale and the strong sponsorship of Brookfield Asset Management provide significant competitive advantages in sourcing and financing growth opportunities.
  • Visible Growth Trajectory Fueled by Decarbonization: The company has a massive development pipeline and is well-positioned to capitalize on the accelerating global demand for clean energy, driven by corporate decarbonization goals and trends like AI and electrification. Management targets 12%-15% long-term total annualized returns, supported by a goal of 5%-9% annual distribution increases.
  • Financial Profile Under Pressure: Despite strong revenue growth and a track record of increasing distributions, the company has consistently reported net losses and negative free cash flow due to high growth-oriented capital expenditures and depreciation. Its high debt load is a key consideration, although near-term maturities are limited and a majority of its debt is at fixed rates.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Industrials: HD Korea Shipbuilding & Offshore Engineering, Fluor Corp, Cosco Shipping Energy Transportation Co. Ltd. (H), CNMC Goldmine Holdings, Forward Air, Nippecraft Ltd, Perak Corp Bhd, Randstad Holding Nv and more

By | Daily Briefs, Industrials

In today’s briefing:

  • Korea’s Next Policy Play: NAV Discount Squeeze on Low‑Float Large Caps
  • Fluor Gets A Jolt As Activist Starboard Pushes For NuScale Breakup!
  • COSCO Shipping Energy (1138 HK): Preparing for Upside Surprise
  • High Trading Activity Stocks Outside the Big-Caps
  • Forward Air Corp (FWRD) – Wednesday, Jul 23, 2025
  • Primer: Nippecraft Ltd (NIP SP) – Oct 2025
  • Primer: Perak Corp Bhd (PRK MK) – Oct 2025
  • Randstad Holding NV – What’s New(s) in Amsterdam


Korea’s Next Policy Play: NAV Discount Squeeze on Low‑Float Large Caps

By Sanghyun Park

  • Market sniffing policy push; low-float names flagged as junk risk with skewed control. Desks circling, Palliser hit early—LG Chem trade popped, timing spot on.
  • Trade setup: screen >₩1tn caps with low float, parent stakes 60–80%. Policy push likely forces stake cuts, driving float higher and squeezing NAV discounts—LG Chem shows the play.
  • Screening >₩1tn caps flags 11 names: parents hold 60–80%. All potential stake-sale plays to boost float, squeeze NAV discount.

Fluor Gets A Jolt As Activist Starboard Pushes For NuScale Breakup!

By Baptista Research

  • Fluor Corporation shares have surged following reports that activist investor Starboard Value has taken a nearly 5% stake in the engineering and construction giant.
  • The rally comes amid growing expectations that Starboard, led by Jeff Smith, will push Fluor to unlock value by exploring strategic alternatives for its 40% stake in NuScale Power, a small modular nuclear reactor (SMR) company that has seen its own stock skyrocket amid AI-driven power demand.
  • With Fluor’s core business lagging and NuScale’s valuation surging, Starboard’s campaign centers on the market’s apparent mispricing of Fluor’s sum-of-the-parts.

COSCO Shipping Energy (1138 HK): Preparing for Upside Surprise

By Osbert Tang, CFA

  • The market consensus is too conservative for Cosco Shipping Energy Transportation Co. (1138 HK). A better-than-expected 3Q25 result is likely to prompt an earnings upgrade.   
  • Spot VLCC rate is 32.7% higher than 1H25 so far for 2H25, and average bunker price has declined 6.2% in 3Q25, both implying improved earnings prospects.
  • With an average ROE for FY25-27 at over 12%, its 1.05x P/B is not stretched. During FY20-23, the average ROE of 1.6% has supported a P/B ratio of 0.56x. 

High Trading Activity Stocks Outside the Big-Caps

By Geoff Howie

  • Among Singapore’s 100 most traded stocks, 22 have a combined ADT of S$42.9 million and market cap of S$8.15 billion.
  • Industrials, Technology, and Energy sectors make up nearly 80% of these stocks, reflecting global trends in infrastructure, AI, and renewables.
  • The 22 stocks recorded a net institutional inflow of S$132.35 million in 2025, led by CSE Global.

Forward Air Corp (FWRD) – Wednesday, Jul 23, 2025

By Value Investors Club (VIC)

Key points (machine generated)

  • Forward Air Corporation is expected to be sold to a financial buyer within two months for around $40, offering a potential return of 30%.
  • The market may be overly pessimistic about the sale’s likelihood and timing, underestimating the deal premium due to the strategic value of Forward Air’s assets.
  • Despite challenges in executing a sale, analysts believe a sale is imminent, with the stock trading around $30.50, below pre-announcement levels.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


Primer: Nippecraft Ltd (NIP SP) – Oct 2025

By αSK

  • Nippecraft is navigating a challenging environment characterized by secular declines in its core stationery business, evidenced by a consistent fall in revenue over the past three years. The company’s strategy to counteract this involves diversification into pulp trading and a focus on lifestyle branding.
  • Despite falling sales, the company has demonstrated an ability to grow net income and EPS over medium-to-long term horizons, suggesting successful cost control and restructuring efforts. However, recent profitability is thin and cash flow generation remains a significant concern, with negative operating and free cash flow in the latest fiscal year.
  • Valuation appears attractive on a price-to-book basis, trading at a significant discount to its book value. This may appeal to value-oriented investors, but the low valuation reflects substantial risks, including the structural decline of the paper products industry and intense competitive pressure.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Primer: Perak Corp Bhd (PRK MK) – Oct 2025

By αSK

  • Perak Corp is a state-linked, diversified investment holding company with core operations in Property Development, Port & Logistics, and Hospitality, but faces significant financial challenges evidenced by its PN17 status.
  • The company is undergoing a crucial financial restructuring via a proposed regularisation plan involving capital reduction, asset sales, and debt settlement, which is critical for its survival and future viability.
  • While recent financial data shows a return to marginal profitability, the company has a history of losses, negative free cash flow, and has not paid dividends, indicating a high-risk investment profile dependent on the successful execution of its turnaround strategy.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Randstad Holding NV – What’s New(s) in Amsterdam

By The IDEA!

  • In this edition: • AkzoNobel | 3Q25 results hit by FX headwind; EUR 300m charge for Project Ichtys • Heineken | 3Q25 volumes disappoint across the board • Randstad | organic revenue per working remains negative and lags its US peer • Unilever | spin-off ice cream unit delayed because of US shutdown • TKH Group | completed divestment of Dewetron • Nexperia | warns customers not to buy chips from its Chinese branch • Dutch politics | EenVandaag poll: Bontenbal most trusted candidate PM

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Energy/Materials: Northern Star Resources, LG Chem Ltd, Crude Oil, SGX Rubber Future TSR20, Cleveland-Cliffs Inc , CNMC Goldmine Holdings, Southern Copper, Eurasia Mining PLC, Base Oil and more

By | Daily Briefs, Energy & Materials Sector

In today’s briefing:

  • Gold Miners ETF (GDX US) Dec Rebalance: Zijin Gold Is a Miss; One Add Likely; US$4.1bn Trade
  • Palliser Capital Goes Activist on LG Chem
  • China’s Expanding Crude Inventories Keep Oil Prices in Check
  • Oil futures: Crude sees late-day rebound amid trade headwinds, supply glut
  • Vietnam Rubber Market Recalibrates On Firming Prices, China Demand
  • Cleveland-Cliffs Drops A Bombshell: Rare Earths, Auto Demand & Tariffs Drive MASSIVE Jump!
  • High Trading Activity Stocks Outside the Big-Caps
  • Copper To End The Year with Seasonal Strength: Onward To 12,000 USD/Ton
  • Eurasia Mining – Update
  • Americas/EMEA base oils supply outlook: Week of 20 October


Gold Miners ETF (GDX US) Dec Rebalance: Zijin Gold Is a Miss; One Add Likely; US$4.1bn Trade

By Brian Freitas


Palliser Capital Goes Activist on LG Chem

By Douglas Kim

  • Palliser Capital started to go activist on LG Chem.  According to Palliser Capital, LG Chem’s share price is trading at a 74% discount to its NAV.
  • Palliser Capital proposed improving the composition of the board of directors, restructuring the executive compensation system to align with shareholder interests, and higher share buybacks. 
  • Our updated NAV analysis of LG Chem suggests implied price of 613,438 won per share, which represents a 57% higher levels than current levels.

China’s Expanding Crude Inventories Keep Oil Prices in Check

By Suhas Reddy

  • China’s aggressive crude stockpiling through 2025 has quietly reduced global supply, cushioning oil prices against a surplus-driven downturn amid OPEC+ supply hikes.
  • By absorbing excess barrels when prices fall and easing purchases when they rise, China’s flexible buying strategy has emerged as a stabilising force in global oil markets.
  • With inventories estimated between 1.4 and 2 billion barrels, China’s future buying pace will hinge on price trends, geopolitical pressures, and internal reserve targets.

Oil futures: Crude sees late-day rebound amid trade headwinds, supply glut

By Quantum Commodity Intelligence

  • Crude oil futures initially struggled Tuesday as global trade tensions and supply glut fears continued to drag on prices before a late-day rebound lifted benchmarks into positive territory on the day.
  • Front-month Dec25 ICE Brent futures were trading at $61.37/b (2010 BST) versus Monday’s settle of $61.01/b, while Dec25 NYMEX WTI was at $57.32/b against a previous close of $57.02/b.
  • Oil markets continued to face growing headwinds, including the latest round of anti-trade measures between Washington and Beijing, putting global economic growth at risk.

Vietnam Rubber Market Recalibrates On Firming Prices, China Demand

By Vinod Nedumudy

  • Vietnam exports 1.12 million tons of rubber in Jan–Aug  
  • Exports to China up 5.9% in volume; value surges 22%  
  • Typhoon Kajiki causes brief disruptions, but exports stay firm  

Cleveland-Cliffs Drops A Bombshell: Rare Earths, Auto Demand & Tariffs Drive MASSIVE Jump!

By Baptista Research

  • Cleveland-Cliffs saw its stock jump 21.5% in a single trading session following a Q3 2025 earnings report that significantly beat EBITDA expectations and unveiled a surprise strategic pivot toward rare earth minerals production.
  • This dramatic move has reenergized investor enthusiasm, particularly as it aligns with broader U.S. policy goals of reducing critical mineral dependence on China.
  • For the third quarter, the company reported adjusted EBITDA of $143 million versus Street estimates of $128 million, with revenue coming in at $4.7 billion.

High Trading Activity Stocks Outside the Big-Caps

By Geoff Howie

  • Among Singapore’s 100 most traded stocks, 22 have a combined ADT of S$42.9 million and market cap of S$8.15 billion.
  • Industrials, Technology, and Energy sectors make up nearly 80% of these stocks, reflecting global trends in infrastructure, AI, and renewables.
  • The 22 stocks recorded a net institutional inflow of S$132.35 million in 2025, led by CSE Global.

Copper To End The Year with Seasonal Strength: Onward To 12,000 USD/Ton

By Sameer Taneja


Eurasia Mining – Update

By Optimo Capital

  • Eurasia Mining joined AIM in 1999 as a Russia-focused metals and mining company.
  • Initially in a JV with Anglo Platinum, the company undertook extensive exploration (gold, gold-copper & PGMs) in the Urals and the Kola Peninsula.
  • This led to the West Kytlim and Monchetundra discoveries that Eurasia went on to acquire.

Americas/EMEA base oils supply outlook: Week of 20 October

By Iain Pocock

  • US base oils prices rise versus feedstock/competing fuel prices, especially for Group II light-grade export prices.
  • Firmer margins point to steady-to-tight supply-demand fundamentals at a time of year when they typically start to weaken.
  • Firmer margins incentivize refiners to maintain or raise output.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief TMT/Internet: Cig Shanghai, Pony AI, Softbank Group, Taiwan Semiconductor (TSMC) – ADR, Nota, Texas Instruments, CCC Intelligent Solutions Hold, Horizon Robotics, Singular Health Group and more

By | Daily Briefs, TMT/Internet

In today’s briefing:

  • CIG Shanghai A/H Listing: Smaller A/H Premium than Larger Peers, Expensive
  • Pony AI HK Dual Primary Listing: The Investment Case
  • SoftBank Soared. And This Hidden AI Power Play Could Be Next
  • Pony AI HK Listing: Turning Driverless Technology into a Commercial Reality
  • Taiwan Tech Weekly: Mediatek & Nvidia Announce GB10 Partnership; TSMC’s Prices Spur Samsung Interest
  • Nota IPO Bookbuilding Analysis
  • TXN 3Q25: Peak Revenue Growth (Recovery) Is Behind Us, Consensus Too High, Stock a Bit Expensive.
  • Correction: CCC Intelligent Solutions (CCCS)
  • Horizon Robotics IPO Lockup – Last of the Lockups, Large Pre-IPO Investors Still Holding On
  • Singular Health Group Ltd – Reinventing medical imaging connectivity


CIG Shanghai A/H Listing: Smaller A/H Premium than Larger Peers, Expensive

By Nicholas Tan

  • Cig Shanghai (603083 CH), telecommunications equipment company, is looking to raise up to US$594m in its upcoming Hong Kong IPO.
  • It is a provider of critical infrastructure components for the development of AI.
  • In this note, we examine the IPO dynamics, and look at the firm’s valuation.

Pony AI HK Dual Primary Listing: The Investment Case

By Arun George

  • Pony AI (PONY US) is a Chinese robotaxi operator and self-driving technology company. It is seeking to raise US$1 billion through a dual primary HKEx listing.     
  • It was listed on the Nasdaq on 27 November 2024, raising US$260 million at US$13.00 per ADS. Since listing, the shares are up 48%.
  • The investment case centres around Pony’s accelerating revenue growth and progress towards positive unit economics. However, the path to profitability is long-dated and the valuation is full. 

SoftBank Soared. And This Hidden AI Power Play Could Be Next

By Finimize Research

  • AI’s evolving every second of every day, and so are the boom’s best investing plays. Early this year, I called out SoftBank Group as a prime AI opportunity.
  • A wide discount to NAV offered a cheap way to invest in Arm and tech, but that’s narrowed after Softbank’s 150% share price rally – and more limited NAV growth.
  • So I’ve taken a fresh look at SoftBank, reviewed my original trade ideas, and found a new undervalued power play that could help you reap a tidy reward.

Pony AI HK Listing: Turning Driverless Technology into a Commercial Reality

By Devi Subhakesan

  • Pony AI , a leading autonomous mbility technology player based in China, proposes to issue no more than 102 million ordinary shares for a secondary listing on the HKEX.
  • From a commercialization standpoint, Pony is transitioning from pilot programs to scaled operations – 2025 could be a pivotal year of mass production for its 7th generation (Gen-7) Robotaxis.
  • Pony is also accelerating its global expansion – it recently announced a partnership with Stellantis, to develop Level 4 autonomous vehicles for the European market.

Taiwan Tech Weekly: Mediatek & Nvidia Announce GB10 Partnership; TSMC’s Prices Spur Samsung Interest

By Vincent Fernando, CFA

  • MediaTek Joins Forces with NVIDIA on the GB10 Superchip — Locally-Run AI Models Are Coming to Your Desktop
  • TSMC’s 2nm Price Hike Spurs Interest in Samsung, But Underscores Its Strength
  • Latest for Smartphone Demand 3Q25: A Little Bit Better, Just a Little 

Nota IPO Bookbuilding Analysis

By Douglas Kim

  • Nota’s IPO price has been confirmed at 9,100 won, which is at the high end of the IPO price range. The demand ratio was 1,058 to 1.
  • Our base case valuation of Nota suggests target price of 11,948 won per share, which is 31% higher than the IPO price (9,100 won). 
  • Nota Provides technology that enables the efficient operation of high-performance AI models even on resource-constrained edge devices, centered around its proprietary AI model optimization platform, NetsPresso®.

TXN 3Q25: Peak Revenue Growth (Recovery) Is Behind Us, Consensus Too High, Stock a Bit Expensive.

By Nicolas Baratte

  • The demand & inventory correction lasted for 9 quarters (4Q22-4Q24) but we’re already past peak recovery in 4Q25. 2-3Q25 revenue growth was ~15% YoY, declining to 10% in 4Q. 
  • 4Q guidance: revenues ok, weak EPS 1) higher tax rate 2) lower production loading. While management says that inventories are at a good level, TXN is cutting down production levels.
  • Consensus is ~10% too high for 2026 & 27, Valuations not attractive, above average.

Correction: CCC Intelligent Solutions (CCCS)

By J Capital Research

  • We made a major mistake in our last newsletter, on CCCS. The big story in insider sales is the exit of private equity owner Advent International, not share sales by directors.
  • Those sales exist, but in much smaller number than we reported.
  • We remain concerned about the exit of directors, and we stand by our thesis that the stock is over-valued.

Horizon Robotics IPO Lockup – Last of the Lockups, Large Pre-IPO Investors Still Holding On

By Sumeet Singh

  • Horizon Robotics (9660 HK) raised around US$800m in its Hong Kong IPO in October 2024. Its first set of lockups expired in April 2025. The next one is due soon.
  • Horizon Robotics (HR) is a provider of advanced driver assistance systems (ADAS) and autonomous driving (AD) solutions for passenger vehicles, empowered by its proprietary software and hardware technologies.
  • In this note, we will talk about the lockup dynamics and possible placement.

Singular Health Group Ltd – Reinventing medical imaging connectivity

By Research as a Service (RaaS)

  • Singular Health Group Limited (ASX:SHG) is an Australian medtech company focused on improving medical data interoperability.
  • Its flagship software, 3DICOMTM, enables the seamless sharing of medical images across incompatible systems – reducing inefficiencies and unnecessary costs.
  • The platform is FDA-cleared in the US and SHG recently secured its first major US commercial deal with Provider Network Solutions (PNS), a Managed Service Organisation (MSO) that works with health plans (health insurers), primary care providers and specialists.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Industrials: HD Korea Shipbuilding & Offshore Engineering, Fluor Corp, Cosco Shipping Energy Transportation Co. Ltd. (H), CNMC Goldmine Holdings, Forward Air, Nippecraft Ltd, Perak Corp Bhd, Randstad Holding Nv and more

By | Daily Briefs, Industrials

In today’s briefing:

  • Korea’s Next Policy Play: NAV Discount Squeeze on Low‑Float Large Caps
  • Fluor Gets A Jolt As Activist Starboard Pushes For NuScale Breakup!
  • COSCO Shipping Energy (1138 HK): Preparing for Upside Surprise
  • High Trading Activity Stocks Outside the Big-Caps
  • Forward Air Corp (FWRD) – Wednesday, Jul 23, 2025
  • Primer: Nippecraft Ltd (NIP SP) – Oct 2025
  • Primer: Perak Corp Bhd (PRK MK) – Oct 2025
  • Randstad Holding NV – What’s New(s) in Amsterdam


Korea’s Next Policy Play: NAV Discount Squeeze on Low‑Float Large Caps

By Sanghyun Park

  • Market sniffing policy push; low-float names flagged as junk risk with skewed control. Desks circling, Palliser hit early—LG Chem trade popped, timing spot on.
  • Trade setup: screen >₩1tn caps with low float, parent stakes 60–80%. Policy push likely forces stake cuts, driving float higher and squeezing NAV discounts—LG Chem shows the play.
  • Screening >₩1tn caps flags 11 names: parents hold 60–80%. All potential stake-sale plays to boost float, squeeze NAV discount.

Fluor Gets A Jolt As Activist Starboard Pushes For NuScale Breakup!

By Baptista Research

  • Fluor Corporation shares have surged following reports that activist investor Starboard Value has taken a nearly 5% stake in the engineering and construction giant.
  • The rally comes amid growing expectations that Starboard, led by Jeff Smith, will push Fluor to unlock value by exploring strategic alternatives for its 40% stake in NuScale Power, a small modular nuclear reactor (SMR) company that has seen its own stock skyrocket amid AI-driven power demand.
  • With Fluor’s core business lagging and NuScale’s valuation surging, Starboard’s campaign centers on the market’s apparent mispricing of Fluor’s sum-of-the-parts.

COSCO Shipping Energy (1138 HK): Preparing for Upside Surprise

By Osbert Tang, CFA

  • The market consensus is too conservative for Cosco Shipping Energy Transportation Co. (1138 HK). A better-than-expected 3Q25 result is likely to prompt an earnings upgrade.   
  • Spot VLCC rate is 32.7% higher than 1H25 so far for 2H25, and average bunker price has declined 6.2% in 3Q25, both implying improved earnings prospects.
  • With an average ROE for FY25-27 at over 12%, its 1.05x P/B is not stretched. During FY20-23, the average ROE of 1.6% has supported a P/B ratio of 0.56x. 

High Trading Activity Stocks Outside the Big-Caps

By Geoff Howie

  • Among Singapore’s 100 most traded stocks, 22 have a combined ADT of S$42.9 million and market cap of S$8.15 billion.
  • Industrials, Technology, and Energy sectors make up nearly 80% of these stocks, reflecting global trends in infrastructure, AI, and renewables.
  • The 22 stocks recorded a net institutional inflow of S$132.35 million in 2025, led by CSE Global.

Forward Air Corp (FWRD) – Wednesday, Jul 23, 2025

By Value Investors Club (VIC)

Key points (machine generated)

  • Forward Air Corporation is expected to be sold to a financial buyer within two months for around $40, offering a potential return of 30%.
  • The market may be overly pessimistic about the sale’s likelihood and timing, underestimating the deal premium due to the strategic value of Forward Air’s assets.
  • Despite challenges in executing a sale, analysts believe a sale is imminent, with the stock trading around $30.50, below pre-announcement levels.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


Primer: Nippecraft Ltd (NIP SP) – Oct 2025

By αSK

  • Nippecraft is navigating a challenging environment characterized by secular declines in its core stationery business, evidenced by a consistent fall in revenue over the past three years. The company’s strategy to counteract this involves diversification into pulp trading and a focus on lifestyle branding.
  • Despite falling sales, the company has demonstrated an ability to grow net income and EPS over medium-to-long term horizons, suggesting successful cost control and restructuring efforts. However, recent profitability is thin and cash flow generation remains a significant concern, with negative operating and free cash flow in the latest fiscal year.
  • Valuation appears attractive on a price-to-book basis, trading at a significant discount to its book value. This may appeal to value-oriented investors, but the low valuation reflects substantial risks, including the structural decline of the paper products industry and intense competitive pressure.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Primer: Perak Corp Bhd (PRK MK) – Oct 2025

By αSK

  • Perak Corp is a state-linked, diversified investment holding company with core operations in Property Development, Port & Logistics, and Hospitality, but faces significant financial challenges evidenced by its PN17 status.
  • The company is undergoing a crucial financial restructuring via a proposed regularisation plan involving capital reduction, asset sales, and debt settlement, which is critical for its survival and future viability.
  • While recent financial data shows a return to marginal profitability, the company has a history of losses, negative free cash flow, and has not paid dividends, indicating a high-risk investment profile dependent on the successful execution of its turnaround strategy.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Randstad Holding NV – What’s New(s) in Amsterdam

By The IDEA!

  • In this edition: • AkzoNobel | 3Q25 results hit by FX headwind; EUR 300m charge for Project Ichtys • Heineken | 3Q25 volumes disappoint across the board • Randstad | organic revenue per working remains negative and lags its US peer • Unilever | spin-off ice cream unit delayed because of US shutdown • TKH Group | completed divestment of Dewetron • Nexperia | warns customers not to buy chips from its Chinese branch • Dutch politics | EenVandaag poll: Bontenbal most trusted candidate PM

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Financials: First Pacific Co, HDFC Bank, Bank Of Queensland, Grupo Catalana Occidente Sa, Bitcoin, Close Brothers, China Vanke , Hargreaves Lansdown, OSB Group and more

By | Daily Briefs, Financials

In today’s briefing:

  • First Pacific (142 HK): Maynilad’s IPO Price Firmed
  • HDFC Bank (HDFCB IN) Tactical Outlook: Time to Lock In Gains
  • Long Bank Of Queensland (BOQ AU) Vs. Short CBA (CBA AU): Proven Stat Arb Pair Trade Returns
  • Catalana Occidente – Inocsa Sweetens Offer: A Modest Bump Amid Sector Outperformance
  • Interpreting Circulating Supply Effects on Token Valuation: MC Vs FDV
  • Primer: Close Brothers (CBG LN) – Oct 2025
  • Lucror Analytics – Morning Views Asia
  • Primer: Hargreaves Lansdown (HL/ LN) – Oct 2025
  • Primer: OSB Group (OSB LN) – Oct 2025


First Pacific (142 HK): Maynilad’s IPO Price Firmed

By David Blennerhassett

  • First Pacific Co (142 HK)‘s 49.9%-held MPIC is spinning off Maynilad, a distributor of potable water and provider of sewage services, on the Philippine exchange.
  • The IPO has been priced at PHP 15/share, down 25% from earlier expectations. Proceeds may reach PHP 34bn (~US$580mn), in the largest Filipino IPO since 2021. 
  • First Pac’s NAV discount has drifted off a recent multi-year narrowing, but remains elevated for a multiple cross-border, difficult to short holdco.

HDFC Bank (HDFCB IN) Tactical Outlook: Time to Lock In Gains

By Nico Rosti

  • Despite good earnings results, HDFC Bank (HDFCB IN) does not seem to be going anywhere. The stock did rally for the past 3 weeks but after the earnings stayed flat.
  • Our quantitative probabilistic model indicates HDFC Bank usually does not rally for more than 4 weeks when this pattern is encountered (we are in the 4th week, this week). 
  • From a price perspective, our model shows a mildly overbought stock, confirming the slow pace. The pullback should be short-lived (1-2 weeks), but it’s imminent.

Long Bank Of Queensland (BOQ AU) Vs. Short CBA (CBA AU): Proven Stat Arb Pair Trade Returns

By Gaudenz Schneider

  • Context: The Bank Of Queensland (BOQ AU) vs. Commonwealth Bank (CBA AU) price-ratio has deviated more than two standard deviations from its one-year average, presenting a potential relative value opportunity.
  • Highlights: Long Bank Of Queensland (BOQ AU) vs. short CBA (CBA AU) targets a 4% return.
  • Why Read: Essential for quantitative traders seeking mean-reversion opportunities, with detailed execution framework, risk management protocols, and historical simulation showing the statistical basis for this relative value play.

Catalana Occidente – Inocsa Sweetens Offer: A Modest Bump Amid Sector Outperformance

By Jesus Rodriguez Aguilar

  • Modest sweetener, same outcome: Inocsa raises its GCO offer to €49.75 (+€0.75/share) after strong sector performance, ensuring fairness optics but still below intrinsic value and peer valuations.
  • Timeline drift, limited spread: Seven-month process extended by repeated dividend-driven adjustments; expected settlement in early Jan-2026, offering ~1% gross spread and ~4.9% annualized return for arbitrageurs.
  • Delisting inevitable: With 62% control and minimal regulatory risk, Inocsa’s bid remains near-certain; minority shareholders face diminishing upside and liquidity risk once Catalana Occidente exits the exchange.

Interpreting Circulating Supply Effects on Token Valuation: MC Vs FDV

By Animoca Brands Research

  • Fully Diluted Valuation (FDV) and Market Capitalisation (MC), while subject to various externalities, are often used as reference points for token valuation. However, this approach is ambiguous for early-stage tokens: Small circulating floats and speculative momentum often inflate FDV, creating uncertainty over whether to benchmark against peers’ FDV or to adjust for differences in circulating supply.
  • We analysed over 800 tokens, regressing circulating supply (%CS) against both Fully Diluted Valuation (FDV) and Market Capitalisation (MC), with results segmented by project maturity and time.
  • Main finding: Throughout most of a token’s life, MC explains valuation behaviour more reliably than FDV. The market anchors on circulating supply rather than total theoretical value.

Primer: Close Brothers (CBG LN) – Oct 2025

By αSK

  • Close Brothers is a UK-based merchant banking group with a focus on specialist lending, securities trading, and formerly, wealth management. The company’s performance is currently overshadowed by the Financial Conduct Authority’s (FCA) investigation into historical motor finance commissions, which has led to a suspension of dividends and significant financial provisions.
  • The core banking business remains resilient, characterized by a prudent lending approach, strong margins, and deep expertise in niche markets. However, the uncertainty surrounding the FCA review presents a material risk to short-to-medium term earnings and capital.
  • Management is taking decisive action to bolster the balance sheet, including the sale of its Asset Management division and a focus on cost discipline. The long-term viability will depend on the final outcome of the regulatory review and the bank’s ability to navigate the evolving economic and regulatory landscape.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Lucror Analytics – Morning Views Asia

By Leonard Law, CFA

  • In today’s Morning Views publication we comment on developments of the following high yield issuers: China Vanke, Japfa Comfeed, New World Development, Softbank Group
  • UST yields declined yesterday, with the curve bull-flattening for the second day. The yield on the 2Y UST was stable at 3.46%, while the yield on the 10Y UST fell 2 bps to 3.96%.
  • Equities halted a two-day rally, while gold and silver retreated from near record-high levels. The S&P 500 was unchanged at 6,735, while the Nasdaq declined 0.2% to 22,954.

Primer: Hargreaves Lansdown (HL/ LN) – Oct 2025

By αSK

  • Impending Private Equity Takeover: Hargreaves Lansdown‘s board has recommended a £5.4bn cash offer from a private equity consortium, signaling a shift from public to private ownership. This move is expected to accelerate the company’s strategic transformation outside the glare of public markets but introduces uncertainty for existing public shareholders.
  • Market Leader Facing Headwinds: As the UK’s largest retail investment platform with a dominant market share and record Assets under Administration (AUA) of £155.3bn, HL boasts significant scale. However, it faces challenges from intense competition, pressure on fees, declining client retention rates, and the need for significant technology investment to maintain its edge.
  • Robust Financials Tempered by Rising Costs: The company has demonstrated strong revenue growth, particularly benefiting from higher interest rates on client cash. However, profitability has been impacted by rising costs associated with strategic investments in technology and a shift towards lower-margin products, a trend that is expected to continue as it evolves its business model.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Primer: OSB Group (OSB LN) – Oct 2025

By αSK

  • OSB Group is a leading specialist mortgage lender in the UK, focusing on underserved segments of the market such as professional Buy-to-Let and specialist residential mortgages. This specialization allows for potentially higher margins and a degree of insulation from the intense competition in the mainstream mortgage market.
  • The company operates a diversified and stable funding model, primarily relying on retail deposits from its Kent Reliance and Charter Savings Bank brands. This is supplemented by access to wholesale funding through securitization platforms and Bank of England schemes, providing financial flexibility.
  • Recent financial performance indicates resilience, with underlying pre-tax profit growth in 2024. However, the company faces headwinds from a subdued UK mortgage market and rising cost-to-income ratios. Future growth is expected to be driven by the expanding specialist lending market, fueled by changing employment and living patterns.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ESG: Despite BoJ’s Post of ETF Sales and more

By | Daily Briefs, ESG

In today’s briefing:

  • Despite BoJ’s Post of ETF Sales, the Path to Normalization in Corporate Governance Remains Distant


Despite BoJ’s Post of ETF Sales, the Path to Normalization in Corporate Governance Remains Distant

By Aki Matsumoto

  • BoJ’s policy of small-scale ETF sales appears to have made inflation curb more difficult due to the yen’s depreciation, although it did not trigger a sharp stock market decline.
  • The ETFs held by BoJ reduce trading liquidity, thereby increasing stock price volatility and limiting the number of Japanese stocks available for investment by major institutional investors.
  • Given that the Bank of Japan’s holdings of ETFs exceed 20% of the issued shares in some companies, the existence of “silent shareholders” is not healthy for corporate governance.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Consumer: WeRide, Yakult Honsha, BYD, Hamee Corp, Lenskart Solutions, Toyota Motor, Pop Mart, Jumbo Interactive, Honeys Holdings Co., Ltd., TSE Tokyo Price Index TOPIX and more

By | Consumer, Daily Briefs

In today’s briefing:

  • WeRide Secondary HK Offering – Is Relatively Cheaper but Lacks Momentum
  • Yakult Honsha (2267 JP): Underperformance & Global Index Deletion in Nov
  • BYD (1211 HK) And JD.com (9618 HK) Lead Expected Swings as 27% of HSI Reports Before Month-End
  • Podcast: An Under-the-Radar Japanese Spin-off
  • Lenskart Solutions Pre-IPO – The Positives – Worth Keeping an Eye On
  • Toyota (7203 JP) Up 3.2% Today: Tactical Bearish Option Strategies as Pullback Looms
  • Primer: Pop Mart (9992 HK) – Oct 2025
  • Diversification Drives Jumbo Growth Outlook
  • Honeys’ Faster, High Profit Fashion
  • Despite BoJ’s Post of ETF Sales, the Path to Normalization in Corporate Governance Remains Distant


WeRide Secondary HK Offering – Is Relatively Cheaper but Lacks Momentum

By Sumeet Singh

  • WeRide (WRD US) plans to raise around US$350m in its secondary listing in Hong Kong.
  • The company won HK listing approval and filed its PHIP on 19th October 2025. It will look to launch its secondary offering soon.
  • In this note, we’ll take a look at the deal and talk about the impact of the raising.

Yakult Honsha (2267 JP): Underperformance & Global Index Deletion in Nov

By Brian Freitas

  • Yakult Honsha (2267 JP)‘s stock price has continued to slide, and the stock is now trading 53% lower than its highs from 18 months ago. 
  • The lower market cap should result in the stock being deleted from a global index in November. The stock has underperformed peers but still trades at higher valuations.
  • There has been increased positioning over the last few weeks. Short interest is higher since end-August but there has been covering in the last couple of weeks.

BYD (1211 HK) And JD.com (9618 HK) Lead Expected Swings as 27% of HSI Reports Before Month-End

By Gaudenz Schneider

  • Context: Several of Hong Kong’s largest companies will report in the coming days, representing 27% of the Hang Seng Index (HSI).
  • Highlight: This Insight identifies which stocks have option-implied swings deviating from historical averages.
  • Why Read: Prepare for earnings season by understanding where single-stock and broader market volatility may be elevated.

Podcast: An Under-the-Radar Japanese Spin-off

By Richard Howe

  • Recently, I had the chance to discuss Hamee Corporation (TSE: 3134) with Evan Bleker of Event Driven Insights.
  • Hamee Corporation will soon spin-off its high margin software business.
  • The company is 2 weeks away from breaking up into two separate companies which both look attractive.

Lenskart Solutions Pre-IPO – The Positives – Worth Keeping an Eye On

By Sumeet Singh

  • Lenskart Solutions is looking to raise about US$1bn in its upcoming India IPO.
  • Lenskart Solutions Limited (LSL) is a technology-driven eyewear company with integrated operations spanning designing, manufacturing, branding and retailing of eyewear products.
  • In this note, we talk about the positive aspects of the deal.

Toyota (7203 JP) Up 3.2% Today: Tactical Bearish Option Strategies as Pullback Looms

By Gaudenz Schneider

  • Context: Toyota Motor (7203 JP) rallied 3.2% in Wednesday’s morning session. Quantitative models highlight potential for a short-term pull-back.
  • Trade Idea: Three actionable option strategies with a bearish tilt are presented, taking advantage of current implied volatility levels and skew.
  • Why Read: This Insight combines directional analysis with volatility signals, highlighting a tactical options strategy where high implied volatility and bearish probabilities align, offering investors defined risk/reward.

Primer: Pop Mart (9992 HK) – Oct 2025

By αSK

  • Pop Mart is a dominant force in the rapidly growing global art toy market, driven by a powerful IP-led business model that fosters a loyal collector base and high-margin revenue streams.
  • Aggressive global expansion is the primary growth vector, with overseas revenue surging and plans to significantly increase its international store footprint, aiming for overseas markets to represent 50% of total sales.
  • Exceptional financial performance, characterized by triple-digit revenue and net income growth, robust margins, and strong operating cash flow, underpins a premium valuation relative to peers.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Diversification Drives Jumbo Growth Outlook

By FNArena

  • The share market has signaled approval of Jumbo Interactive’s UK acquisition as management diversifies away from lottery retailing.
  • -Jumbo Interactive acquires Dream Car Giveaways?
  • in the UK -FY26 guidance unchanged, forecasts raised -Lower future volatility anticipated around jackpots -Synergies via Oz Lotteries platform & UK B2C

Honeys’ Faster, High Profit Fashion

By Michael Causton

  • Honeys Holdings is leveraging its SPA model to drive growth using a data-driven rapid decision-making process to capture demand in the tough womenswear market.
  • It has managed to grow sales for five straight years while also rebuilding supply chains, with some of the highest gross margins in the industry.
  • While margins have been hit by higher import costs due to the weak Yen, and higher labour costs, Honeys is squeezing costs further to make up for this.

Despite BoJ’s Post of ETF Sales, the Path to Normalization in Corporate Governance Remains Distant

By Aki Matsumoto

  • BoJ’s policy of small-scale ETF sales appears to have made inflation curb more difficult due to the yen’s depreciation, although it did not trigger a sharp stock market decline.
  • The ETFs held by BoJ reduce trading liquidity, thereby increasing stock price volatility and limiting the number of Japanese stocks available for investment by major institutional investors.
  • Given that the Bank of Japan’s holdings of ETFs exceed 20% of the issued shares in some companies, the existence of “silent shareholders” is not healthy for corporate governance.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Health Care: LIVSMED, Johnson & Johnson, Evommune, Anebulo Pharmaceuticals , Quest Diagnostics , Cooper Cos, Vigonvita Life Sciences, Femasys , Gn Store Nord A/S, Mesoblast Ltd and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • LivsMed IPO Preview
  • Weekly Update (JNJ, LEN/MLR, SOLS)
  • Evommune Inc. (EVMN): Chronic Inflammatory Biotech Sets Terms Seeking up to $511m Valuation
  • Anebulo Pharma Inc (ANEB) – Wednesday, Jul 23, 2025
  • Quest Diagnostics Inc (DGX) – Wednesday, Jul 23, 2025
  • The Cooper Companies Gets Activist Wake-Up Call: Jana Eyes Bausch + Lomb Tie-Up!
  • Pre-IPO Vigonvita Life Sciences (PHIP Updates) – Some Points Worth the Attention
  • Femasys Inc (FEMY) – Wednesday, Jul 23, 2025
  • Primer: Gn Store Nord A/S (GN DC) – Oct 2025
  • Mesoblast (MSB AU): Strong Q1 Result; Ryoncil Commercialization and Pipeline Progress Hold Key


LivsMed IPO Preview

By Douglas Kim

  • LivsMed is getting ready to complete its IPO on the KOSDAQ exchange in December 2025. LivsMed is a medical device manufacturer that specialises in minimally invasive surgery products.
  • This is expected to be one of the largest IPOs in KOSDAQ in 2025.  The IPO price range is from 44,000 won to 55,000 won per share.
  • LivesMed has commercialized the world’s first multi-joint, multi-degree-of-freedom (DOF) technology capable of 90° rotation in all directions.

Weekly Update (JNJ, LEN/MLR, SOLS)

By Richard Howe

  • There is a good amount of froth in the market.
  • The “Fear & Greed Index” has slipped into “Extreme Fear” which is usually a good contra-indicator.
  • For what it’s worth, I’m still finding plenty of ideas that look attractive from a “bottom up” perspective.

Evommune Inc. (EVMN): Chronic Inflammatory Biotech Sets Terms Seeking up to $511m Valuation

By IPO Boutique

  • Evommune (EVMN US) is set to offer 9.375 million shares at $15-$17 and is slated for a debut of November 6th on the NYSE.
  • According to the prospectus, the underwriters have reserved up to 5% of the shares at the initial public offering price in a directed share program.
  • The company has a handful of license agreements which could boost the profile of this biotech. 

Anebulo Pharma Inc (ANEB) – Wednesday, Jul 23, 2025

By Value Investors Club (VIC)

Key points (machine generated)

  • Anebulo Pharmaceuticals plans a significant reverse stock split to cash out small shareholders at $3.50 per share.
  • The reverse split aims to reduce record holders below 300, avoiding SEC reporting and saving $1.3 million annually.
  • The author, currently shorting the stock, warns of the $1.8 million costs of the transaction and advises independent research.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


Quest Diagnostics Inc (DGX) – Wednesday, Jul 23, 2025

By Value Investors Club (VIC)

Key points (machine generated)

  • Quest Diagnostics is a leading diagnostic health information provider in the U.S. with projected revenues of $9.9 billion in 2024, increasing to $11.2 billion by 2026.
  • The company operates in a duopoly with LabCorp, granting it significant pricing power despite challenges like high fixed costs and complex reimbursement processes.
  • Quest’s focus on dividends and share repurchases indicates strong investment appeal and potential for sustained profitability.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


The Cooper Companies Gets Activist Wake-Up Call: Jana Eyes Bausch + Lomb Tie-Up!

By Baptista Research

  • Cooper Companies surged over 6.5% in premarket trading following a bombshell report that activist investor Jana Partners has taken a stake in the company and is pushing for sweeping strategic changes, including a high-profile merger of its contact lens unit with rival Bausch + Lomb.
  • The news, first reported by the Wall Street Journal, has sent shockwaves through the vision care industry.
  • Jana, known for catalyzing structural change across multiple sectors, is also urging Cooper to improve its capital allocation and returns, hinting at broader dissatisfaction with management’s operational strategy.

Pre-IPO Vigonvita Life Sciences (PHIP Updates) – Some Points Worth the Attention

By Xinyao (Criss) Wang

  • Vigonvita’s product revenue is unlikely to show significant improvement in short term. Whether Vigonvita can avoid the pitfalls that peers have fallen into remains to be tested by the market.
  • With a large amount of idle production capacity, the rationality and necessity of the IPO fundraising plan still including the construction of a new factory in Qingdao are questionable.
  • Vigonvita’s valuation is mainly based on the commercialization of TPN171/VV116. If sales of TPN171 is poor or clinical trial of VV116 fails, valuation will face the risk of significant decline.

Femasys Inc (FEMY) – Wednesday, Jul 23, 2025

By Value Investors Club (VIC)

Key points (machine generated)

  • Femasys specializes in minimally invasive solutions for women’s reproductive health, targeting a $3 billion market.
  • The company has FDA clearance and CE marking for four products, including FemaSeed and FemBloc, which is in pivotal trials.
  • Femasys faces liquidity risks due to convertible debt maturities but has a history of successful fundraising, presenting potential investment opportunities.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


Primer: Gn Store Nord A/S (GN DC) – Oct 2025

By αSK

  • GN Store Nord is a global leader in intelligent audio solutions, operating through three main segments: Hearing, Enterprise, and Gaming.
  • The company is strategically focusing on its core, higher-margin businesses by divesting from the competitive consumer earbuds market to reallocate resources to its Hearing, Enterprise, and Gaming divisions.
  • While facing challenges in the enterprise market, the Hearing division is demonstrating robust growth, driven by new product launches and market share gains.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Mesoblast (MSB AU): Strong Q1 Result; Ryoncil Commercialization and Pipeline Progress Hold Key

By Tina Banerjee

  • Mesoblast Ltd (MSB AU) has reported Q1FY26 product revenue of $20.6M, up from $12.9M in the previous quarter, with Ryoncil gross sales increasing 66% QoQ.
  • With mandatory state CMS coverage becoming effective as of July 1 in all U.S. states and Mesoblast completing onboarding of the remaining major U.S. transplant centers, Ryoncil revenue is accelerating.
  • Mesoblast ended September quarter with $145M in cash. Considering current pace of cash outgo, the company estimates that the current cash should provide runway of approximately 10 more quarters.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ECM: WeRide Secondary HK Offering – Is Relatively Cheaper but Lacks Momentum and more

By | Daily Briefs, ECM

In today’s briefing:

  • WeRide Secondary HK Offering – Is Relatively Cheaper but Lacks Momentum
  • CIG Shanghai A/H Listing: Smaller A/H Premium than Larger Peers, Expensive
  • Pony AI HK Dual Primary Listing: The Investment Case
  • Pony AI HK Listing: Turning Driverless Technology into a Commercial Reality
  • Lenskart Solutions Pre-IPO – The Positives – Worth Keeping an Eye On
  • LivsMed IPO Preview
  • Nota IPO Bookbuilding Analysis
  • Evommune Inc. (EVMN): Chronic Inflammatory Biotech Sets Terms Seeking up to $511m Valuation
  • Pre-IPO Vigonvita Life Sciences (PHIP Updates) – Some Points Worth the Attention


WeRide Secondary HK Offering – Is Relatively Cheaper but Lacks Momentum

By Sumeet Singh

  • WeRide (WRD US) plans to raise around US$350m in its secondary listing in Hong Kong.
  • The company won HK listing approval and filed its PHIP on 19th October 2025. It will look to launch its secondary offering soon.
  • In this note, we’ll take a look at the deal and talk about the impact of the raising.

CIG Shanghai A/H Listing: Smaller A/H Premium than Larger Peers, Expensive

By Nicholas Tan

  • Cig Shanghai (603083 CH), telecommunications equipment company, is looking to raise up to US$594m in its upcoming Hong Kong IPO.
  • It is a provider of critical infrastructure components for the development of AI.
  • In this note, we examine the IPO dynamics, and look at the firm’s valuation.

Pony AI HK Dual Primary Listing: The Investment Case

By Arun George

  • Pony AI (PONY US) is a Chinese robotaxi operator and self-driving technology company. It is seeking to raise US$1 billion through a dual primary HKEx listing.     
  • It was listed on the Nasdaq on 27 November 2024, raising US$260 million at US$13.00 per ADS. Since listing, the shares are up 48%.
  • The investment case centres around Pony’s accelerating revenue growth and progress towards positive unit economics. However, the path to profitability is long-dated and the valuation is full. 

Pony AI HK Listing: Turning Driverless Technology into a Commercial Reality

By Devi Subhakesan

  • Pony AI , a leading autonomous mbility technology player based in China, proposes to issue no more than 102 million ordinary shares for a secondary listing on the HKEX.
  • From a commercialization standpoint, Pony is transitioning from pilot programs to scaled operations – 2025 could be a pivotal year of mass production for its 7th generation (Gen-7) Robotaxis.
  • Pony is also accelerating its global expansion – it recently announced a partnership with Stellantis, to develop Level 4 autonomous vehicles for the European market.

Lenskart Solutions Pre-IPO – The Positives – Worth Keeping an Eye On

By Sumeet Singh

  • Lenskart Solutions is looking to raise about US$1bn in its upcoming India IPO.
  • Lenskart Solutions Limited (LSL) is a technology-driven eyewear company with integrated operations spanning designing, manufacturing, branding and retailing of eyewear products.
  • In this note, we talk about the positive aspects of the deal.

LivsMed IPO Preview

By Douglas Kim

  • LivsMed is getting ready to complete its IPO on the KOSDAQ exchange in December 2025. LivsMed is a medical device manufacturer that specialises in minimally invasive surgery products.
  • This is expected to be one of the largest IPOs in KOSDAQ in 2025.  The IPO price range is from 44,000 won to 55,000 won per share.
  • LivesMed has commercialized the world’s first multi-joint, multi-degree-of-freedom (DOF) technology capable of 90° rotation in all directions.

Nota IPO Bookbuilding Analysis

By Douglas Kim

  • Nota’s IPO price has been confirmed at 9,100 won, which is at the high end of the IPO price range. The demand ratio was 1,058 to 1.
  • Our base case valuation of Nota suggests target price of 11,948 won per share, which is 31% higher than the IPO price (9,100 won). 
  • Nota Provides technology that enables the efficient operation of high-performance AI models even on resource-constrained edge devices, centered around its proprietary AI model optimization platform, NetsPresso®.

Evommune Inc. (EVMN): Chronic Inflammatory Biotech Sets Terms Seeking up to $511m Valuation

By IPO Boutique

  • Evommune (EVMN US) is set to offer 9.375 million shares at $15-$17 and is slated for a debut of November 6th on the NYSE.
  • According to the prospectus, the underwriters have reserved up to 5% of the shares at the initial public offering price in a directed share program.
  • The company has a handful of license agreements which could boost the profile of this biotech. 

Pre-IPO Vigonvita Life Sciences (PHIP Updates) – Some Points Worth the Attention

By Xinyao (Criss) Wang

  • Vigonvita’s product revenue is unlikely to show significant improvement in short term. Whether Vigonvita can avoid the pitfalls that peers have fallen into remains to be tested by the market.
  • With a large amount of idle production capacity, the rationality and necessity of the IPO fundraising plan still including the construction of a new factory in Qingdao are questionable.
  • Vigonvita’s valuation is mainly based on the commercialization of TPN171/VV116. If sales of TPN171 is poor or clinical trial of VV116 fails, valuation will face the risk of significant decline.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars